Substituted imidazopyridazines as PI3K lipid kinase inhibitors

Details for Australian Patent Application No. 2008250328 (hide)

Owner Novartis AG

Inventors Imbach, Patricia; Furet, Pascal; Capraro, Hans-Georg; Caravatti, Giorgio

Agent Davies Collison Cave

Pub. Number AU-A-2008250328

PCT Pub. Number WO2008/138834

Priority 07107833.1 09.05.07 EP

Filing date 7 May 2008

Wipo publication date 20 November 2008

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

26 November 2009 PCT application entered the National Phase

  PCT publication WO2008/138834 Priority application(s): WO2008/138834

27 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008250331-Method and system for automatically keeping travel data consistent between passenger reservation records and corresponding electronic tickets

2008250324-Kit for a body-shell structure